State Board of Administration of Florida Retirement System’s Vascular Solutions Inc VASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,664
Closed -$598K 2379
2016
Q4
$598K Hold
10,664
﹤0.01% 1768
2016
Q3
$514K Hold
10,664
﹤0.01% 1824
2016
Q2
$444K Buy
10,664
+288
+3% +$10.7K ﹤0.01% 1854
2016
Q1
$338K Hold
10,376
﹤0.01% 1995
2015
Q4
$357K Buy
10,376
+1,558
+18% +$52.8K ﹤0.01% 2028
2015
Q3
$286K Hold
8,818
﹤0.01% 2120
2015
Q2
$306K Buy
8,818
+149
+2% +$4.86K ﹤0.01% 2170
2015
Q1
$263K Hold
8,669
﹤0.01% 2228
2014
Q4
$235K Hold
8,669
﹤0.01% 2316
2014
Q3
$214K Buy
+8,669
New +$206K ﹤0.01% 2347
2014
Q2
Sell
-8,524
Closed -$223K 2570
2014
Q1
$223K Buy
+8,524
New +$212K ﹤0.01% 2320

Other funds holding VASC

State Board of Administration of Florida Retirement System's VASC Position: Q1 2017 in Review

State Board of Administration of Florida Retirement System sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 10,664 shares — an estimated $598K sold.

State Board of Administration of Florida Retirement System first reported a position in VASC in Q1 2014 and held it in 11 quarters. The position peaked at $598K in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • State Board of Administration of Florida Retirement System reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 10,664 Vascular Solutions Inc shares in Q1 2017, an estimated $598K.
  • State Board of Administration of Florida Retirement System first reported a position in Vascular Solutions Inc in Q1 2014 and held it in 11 quarters.
  • State Board of Administration of Florida Retirement System's Vascular Solutions Inc position peaked at $598K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2017, filed 2 May 2017.